The terms of the settlement are confidential, according to the lawyers involved in the case. The trial was scheduled to begin recently in US District Court in Cleveland.
READ MORE MRI HEALTH RISK LEGAL NEWS
The case in Cleveland centered around 68-year-old plaintiff Loralei Knase of Coon Rapids, Minnesota. Knase claimed that after being injected with Omniscan for a number of MRI scans between 2003 and 2005, she developed symptoms of nephrogenic system fibrosis in the fall of 2005 and is currently permanently disabled.
In September, ProPublica reported that the FDA advised that Omniscan should not be administered to patients with severe kidney problems due to the risk of developing the disease.